Olejek czosnkowy – skład chemiczny, działanie farmakologiczne i lecznicze

1. Lutomski J. Fascynacja czosnkiem – wczoraj i dziś. Post Fitoter 2001; 5:7-14. 2. Koch HP. „Knoblauch” Wie dosiert man richtig? Dtsch Apoth Ztg 1988; 128(8):408-12. 3. Miething H. Allicin und Öl In Knoblauchzwiebeln- HPLC- Gehaltsbestimung. Dtsch Apoth Ztg 1985; 125(41):2049-50. 4. Vernin G, Metzger J, Fraisse D. GC-MC (EJ, PJC, NCJ) Computer analysis of volatile sulfur compoumds in garlic essential oils. Application of the mass fragmentometry SIM Technique. Planta Med 1986; 36:96-101. 5. Lutomski J. Compounds and biological properties of some allium species. Publication Institute of Medical Plants, Poznań, 1987. 6. Stoll A, Seebeck E. Uber Allicin, die gennine-Muttersubstanz des Knoblauchöls. 1. Mittelung. Helv Chim Acta 1948; 31:189-210. 7. Tchiersch B. Neue aminosauren in hoheren Pflanzen. Pharmazie 1962; 17:721-30. 8. Lutomski J. Die Bedeutung von Knoblauch-Preparaten in der Phytotherapie. Pharmazie u. Zeit. 1980; 9:45. 9. Ożarowski A. Ziołolecznictwo. Warszawa PZWL 1976. 10. Samochowiec L. Kompedium ziołolecznictwa. Wyd Med Urban i Partner, Wrocław 1995. 11. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutr J 2002; 1(4):4-32. 12. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12(4):564-82. 13. Naganawa R, Iwata N, Ishikawa K i wsp. Inhibition of microbial growth by ajoene, a sulfur-containing compound derived from garlic. Appl Environ Microbiol 1996; 62(11):4238-42. 14. Jozani NH, Shahabi S, Ali AA i wsp. In vitro antibacterial activity of garlic against isolates of Acinetobacter sp. J Biol Sci 2007; 7(5):819-22. 15. Tynecka Z, Gos Z. The inhibitory action of garlic on growth and respiration of some microorganisms. Acta Microbiol Pol 1973; 5:51-6. 16. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect 1999; 1:125-9. 17. Ross ZM, O´Gara EA, Hill DJ i wsp. Antimicrobial properties of garlic oil against human enteric bacteria: evaluation of methodologies and comparison with garlic oil sulfides and garlic powder. Appl Environ Microbiol 2001; 67:475-80. 18. Ruddock PS, Liao M, Foster BC i wsp. Garlic natural health products exhibit variable constituent levels and antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. Phytother Res 2005; 19:327-34. 19. O´Gara EA, Hill DJ, Maslin DJ. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Microbiol 2000; 66:2269-73. 20. Cellini L, Di Campli E, Masulli M i wsp. Inhibition of Helicobacter pylori by extract ( Allium sativum). FEMS Immunol Med Microbiol 1996; 13:273-7. 21. Tsao S, Hsu C, Jin M. Garlic extract and two diallyl sulphides inhibit methicillin-resistant Staphylococcus aureus infection in BALB /cA mice. J Antimicrobiol Chemother 2003; 52:974-80. 22. Kędzia A. Działanie na bakterie beztlenowe alkoholowego wyciągu z czosnku ( Allium sativum L.). Herba Pol 1999; 54(1):27-32. 23. Ismaiel A, Pierson MD. Inhibition of growth and germination of C. botulinum 33A, 40B and 1623E by essential oils of species. J Food Sci 1990; 55:1676-8. 24. Maruzzella JC, Sicurella NA. Antibacterial activity of essential oil vapors. J Am Pharm Assoc 1960; 49:692-4. 25. Tsao S, Yin M. In vitro of garlic oil and four diallyl sulphides against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother 2001; 47:665-70. 26. Tsao S, Yin M. In vitro antimicrobial activity of four diallyl sulphides occurring naturally in garlic and Chinese leek oils. J Med Microbial 2001; 50:646-9. 27. Kędzia A. Działanie olejku czosnkowego na bakterie beztlenowe wyodrębnione z jamy ustnej i górnych dróg oddechowych. Post Fitoter 2000; 1:28-31. 28. Pyun MS, Shin S. Antifungal effects of the volatile oils from Allium plants against Trichophyton species and synergism of the oils with ketoconazole. Phytomedicine 2006; 13:394-400. 29. Bordia A, Verma SK, Vyas AK i wsp. Effect of essential oil of onion and garlic on experimental atherosclerosis in rabbits. Atherosclerosis 1977; 26(3):379-86. 30. Gebhardt R, Bech H. Differential inhibitory effect of garlic-derived organo sulfur compounds on cholesterol biosyntesis in primary rat hepatocyte culture. Lipids 1996; 31:1269-76. 31. Yeh YY, Lin L. Cholesterol lowering effect of garlic extracts and organosulphur compounds: Human and animal studies. J Nutr 2001; 131:989-93. 32. Bordia A, Arora SK, Kothari LK i wsp. The protective action of essential oils of anion and garlic in cholesterol-fed rabbits. Atherosclerosis 1975; 22:103-9. 33. Kritchevsky D. Effect of garlic oil on experimental atherosclerosis in rabbits. Artery 1975; 1:319-23. 34. Bordia AK, Joshi HK, Sandya YK i wsp. Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease. Atherosclerosis 1977; 28:155-8. 35. Bordia SK. Protective effect of garlic oil on the changes production by 3 weeks of fatty diet on serum cholesterol, serum triglycerides, fibrinolytic activity and platelet adhesiveness in man. Ind Heart J 1982; 34:86-92. 36. Ali M. Mechanism by which garlic ( Allium sativum) inhibits cyclooxygenase activity. Effect of raw versus boiled garlic extract on the synthesis of ptostanoids. Prostoglandins Leukot Essent Fatty Acids 1995; 53:397-400. 37. Apitz-Castro R, Escalante J, Vargas R i wsp. Ajoene, the antiplated principle of garlic, synergistically potentiates the antiaggregatory action of prosthacyclin, forsholin, indomethacin and dypiridamole on human platelets. Thromb Res 1986; 42:303-11. 38. Bordia A, Verma SK, Srivastava KC. Effect of garlic ( Allium sativum) on blood, lipids, blood sugar, fibrinogen and fibrynolytic activity in patients with coronary artery disease. Prostoglandins Leukot Essent Fatty Acids 1998; 52:257-63. 39. Sharif AM, Darabi R, Akbarloo N. Investigation of antihypertensive mechanism of garlic in 2k1C hypertensive rat. J Ethopharmacol 2003; 86:219-24. 40. Zheziang Institute of Traditional Chinese Medicine. The effect of essential oil of garlic on hyperlipidemia and platelet aggregation – an analysis of 308 cases. Cooperative Group for Essential Oil of Garlic. J Tradit Chin Med 1986; 6:117-20. 41. Tisserand R, Balacs T. Essential oil safety. Edinburg, Churchil Livingstone. 1995. 42. Jain RC, Vyas CR. Garlic in alloxan-induced diabetic rabbits. Am J Clin Nutr 1975; 28:684-5. 43. Jain RC, Vyas CR, Mahatma OP. Hypoglicemic action of onion and garlic. Lancet 1973; 2:1491-5. 44. Zhang XH, Lowe D, Giles P i wsp. Gender may affect the action of garlic oil on plasma cholesterol subjects. J Nutr 2001; 131:1471-8. 45. Jain RC, Vayas CR. Hypoglycemia action of onion on rabbits. Br Med J 1974; 2:730-3. 46. Chang MLW, Johnson MA. Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J Nutr 1980; 110:931-6. 47. Kiesewetter H, Jung F, Pindur G i wsp. Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J Clin Pharmacol Ther Toxicol 1991; 29:151-5. 48. Abraham KO, Shankaranarayana ML, Raghavan B. Allium – varietas chemistry and analysis. Lebensm-Wiss U Techn 1976; 9:193-200. 49. Wu CC, Shenn LY, Chen W i wsp. Effect of organosulfur compounds from garlic oil on the antioxidation system in rat liver and red blood cells. Food Chem Toxicol 2001; 39(6):563-9. 50. Hassan HA, El-Agmy SM, Gaur RL i wsp. In vitro evidence of hepato- and reno-protective effect of garlic oil against nitrite-induced oxidative stress. Int J Bio Sci 2009; 5(3):249-55. 51. Pedraza-Chaverri J, Maldonado PD, Barrera D i wsp. Protective effect of diallyl sulfide on oxidative stress and nephrotoxicity induced by gentamicin in rats. Mol Cell Biochem 2003; 254:125-30. 52. Popova MA, Popova CS. Effect of chemical agents on some enzyme activities and on the stability of membrane structures. Bulg J Vet Med 2005; 8:163-71. 53. Salavanan G, Prakash J. Effect of garlic ( Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. J Ethnopharmacol 2004; 94:155-8. 54. Wu CC, Shen LY, Chen HW i wsp. Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats. J Agric Food Chem 2002; 50(21):378-83. 55. Wu CC, Sheen LY, Chen HW. Effect of garlic oil and its organosulfur compounds on the activities of hepatic drug-metabolizing and oxidant enzymes in rats fed high-and low-fat diets. Nutr Cancer 1999; 35:160-6. 56. Milner JA. A historical perspective on garlic and cancer. J Nutr 2001; 131:10273-315. 57. Hamada S, Kamada M, Furumoto H i wsp. Expression of glutatione s-transferase-pi in human ovaria cancer as an indicator of resistance to chemotherapy. Ginecol Oncol 1994; 52:313-9. 58. Seki T, Fsuji K, Hayato Y. Garlic and onion oils inhibits proliferation and induce differentiation of HL-60 cells. Cancer Lett 2000; 160:29-35. 59. Khaunum F, Anilakmar KR, Sudarshanakrishna KR. Effect of feeding fresh garlic and garlic oil on detoxyifying enzymes as micronuclei formation in rats treated with azoxymethane. Ind J Vit Nutr Res 1998; 68:208-13. 60. Wu C, Chung J, Tsai S i wsp. Differential effect of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells. Food Chem Toxixol 2004; 42:1937-45. 61. Benjamin H., Lau M, Padma P i wsp. Allium sativum (Garlic) and other cancer prevention. Nutr Res 1990; 10:937-48. 62. Thomson M, Ali M. Garlic: A review of its potential use as an anti-cancer agent. Curr Cancer Drug Tangets 2003; 3:267-381. 63. Muldner T, Verspaget H, Sierc C. Glutathione s-transferase-pi in colorectal tumors is predictive for overall survival. Cancer Res 1995; 55:2696-702. 64. Sansham AS, Rao AW, Kucheria K. Inhibitory action of garlic oil in the initiation of benzo(a)pyrene-induced skin carcinogenesis in mice. Cancer Lett 1988; 40:193-7. 65. Lutomski J, Alkiewicz J. Leki roślinne w profilaktyce i terapii. PZWL Warszawa 1993. 66. Kędzia B. Olejki eteryczne i preparaty olejkowe w leczeniu chorób wewnętrznych. Wiad Ziel 2000; 1:2-7.